This was due to the fact that combined blockade resulted in higher levels of cytokines (IFN-γ, TNF-α, and granzyme B) production by tumor-specific CD8+ T cells from tumor-draining lymph nodes compared to single blockade or control group 142. The gene discussed is CD8A; the disease is neoplasm.